Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design
收藏NBER2015-08-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w21499
下载链接
链接失效反馈官方服务：
资源简介：
Implicit in the drug-approval process is a trade-off between Type I and Type II error. We explore the application of Bayesian decision analysis (BDA) to minimize the expected cost of drug approval, where relative costs are calibrated using U.S. Burden of Disease Study 2010 data. The results for
提供机构：
美国国家经济研究局创建时间：
2015-08-01
